Drugs that contain Frovatriptan Succinate
1. Frova patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5962501 | ENDO PHARMS | Enantiomer of carbazole derivative as 5-HT1-like agonists |
Dec, 2013
(10 years ago) | |
| US5616603 | ENDO PHARMS | Enantiomers of carbazole derivatives as 5-HT1 -like agonists |
Apr, 2014
(10 years ago) | |
| US5637611 | ENDO PHARMS | Medicaments |
Jun, 2014
(9 years ago) | |
| US5827871 | ENDO PHARMS | Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof |
Oct, 2015
(8 years ago) | |
| US5464864 | ENDO PHARMS | Use of tetrahydrocarbazone derivatives as 5HT1 receptor agonists |
Nov, 2015
(8 years ago) | |
Market Authorisation Date: 08 November, 2001
Treatment: Acute treatment of migraine attacks with or without aura in adults
Dosage: TABLET;ORAL
How can I launch a generic of FROVA before it's drug patent expiration?
More Information on Dosage
FROVA family patents
